Literature DB >> 16246523

Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodies.

Naoya Goto1, Kazumitsu Sugiura, Yasushi Ogawa, Akihiro Watanabe, Hiroki Onouchi, Yasushi Tomita, Yoshinao Muro.   

Abstract

p80 coilin is a nuclear autoantigen that strongly accumulates in Cajal bodies (CB) and is considered a marker for CBs. No clear clinical features have been associated with anti-p80 autoantibodies, and the epitopes recognized by these antibodies are entirely unknown. We determined the epitope specificity for 34 anti-p80 coilin-positive sera from Japanese patients to better understand its clinical significance. Western blotting and immunoprecipitation analysis revealed that the autoepitope of p80 coilin was restricted to a single region encompassing amino acid residues 421-576 from the C-terminus of p80 coilin. Additionally, sera from 30 of 34 (88%) patients with anti-p80 coilin antibody titers were also positive for anti-DFS70/LEDGF antibody. This autoantibody is sometimes found in patients with some allergic diseases but rarely in patients with connective tissue disease (CTD). Other similar characteristics between these two autoantibodies were also noted. In contrast, few anti-p80 coilin positive patients were positive for CTD-marker antibodies, such as anti-Sm, anti-dsDNA, and anti-SS-A. We conclude that the presence of anti-p80 coilin autoantibodies is not associated with any particular clinical syndromes nor is it diagnostic of any conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246523     DOI: 10.1016/j.jaut.2005.09.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  9 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

2.  Clinical use of anti-DFS70 autoantibodies.

Authors:  So Young Kang; Woo In Lee; Myeong Hee Kim; You La Jeon
Journal:  Rheumatol Int       Date:  2019-04-10       Impact factor: 2.631

3.  Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2.

Authors:  Anamika Basu; Leanne Woods-Burnham; Greisha Ortiz; Leslimar Rios-Colon; Johnny Figueroa; Roger Albesa; Luis E Andrade; Michael Mahler; Carlos A Casiano
Journal:  Clin Immunol       Date:  2015-07-31       Impact factor: 3.969

Review 4.  Cell damage and autoimmunity: a critical appraisal.

Authors:  Ian R Mackay; Natasha V Leskovsek; Noel R Rose
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

Review 5.  [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].

Authors:  R Mierau
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 6.  The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Authors:  Robert L Ochs; Michael Mahler; Anamika Basu; Leslimar Rios-Colon; Tino W Sanchez; Luis E Andrade; Marvin J Fritzler; Carlos A Casiano
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

7.  Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.

Authors:  John B Carter; Sara Carter; Sandra Saschenbrecker; Bruce E Goeckeritz
Journal:  Front Med (Lausanne)       Date:  2018-04-09

8.  Association between autoimmune reactions and severity of atopic dermatitis in children with herpes virus infection.

Authors:  Pavel Samoylikov; Valentina Gervazieva; Sergey Kozhevnikov
Journal:  World Allergy Organ J       Date:  2013-04-29       Impact factor: 4.084

9.  The Impact of Coilin Nonsynonymous SNP Variants E121K and V145I on Cell Growth and Cajal Body Formation: The First Characterization.

Authors:  Yue Yao; Heng Wee Tan; Zhan-Ling Liang; Gao-Qi Wu; Yan-Ming Xu; Andy T Y Lau
Journal:  Genes (Basel)       Date:  2020-08-05       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.